We are live on ! Find out more
CRL icon

Charles River Laboratories
CRL

644 hedge funds and large institutions have $13.5B invested in Charles River Laboratories in 2022 Q1 according to their latest regulatory filings, with 60 funds opening new positions, 262 increasing their positions, 235 reducing their positions, and 115 closing their positions.

New
Increased
Maintained
Reduced
Closed

11% more repeat investments, than reductions

Existing positions increased: 262 | Existing positions reduced: 235

0.8% more ownership

Funds ownership: 93.47% → 94.28% (+0.8%)

1% less call options, than puts

Call options by funds: $77.7M | Put options by funds: $78.4M

9% less funds holding

Funds holding: 707 → 644 (-63)

24% less capital invested

Capital invested by funds: $17.7B → $13.5B (-$4.23B)

48% less first-time investments, than exits

New positions opened: 60 | Existing positions closed: 115

53% less funds holding in top 10

Funds holding in top 10: 15 → 7 (-8)

Holders
644
Holders Change
-63
Holders Change %
-8.91%
% of All Funds
10.16%
Holding in Top 10
7
Holding in Top 10 Change
-8
Holding in Top 10 Change %
-53.33%
% of All Funds
0.11%
New
60
Increased
262
Reduced
235
Closed
115
Calls
$77.7M
Puts
$78.4M
Net Calls
-$664K
Net Calls Change
-$48.1M

Top Buyers

1
Mackenzie Financial
Mackenzie Financial
Ontario, Canada
+$171M
2
ClearBridge Investments
ClearBridge Investments
New York
+$92.9M
3
Fidelity International
Fidelity International
Bermuda
+$83.3M
4
Two Sigma Investments
Two Sigma Investments
New York
+$53.3M
5
JMPWA
JP Morgan Private Wealth Advisors
California
+$47M

Top Sellers

1
Invesco
Invesco
Georgia
-$142M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$118M
3
Brown Advisory
Brown Advisory
Maryland
-$111M
4
Marshall Wace
Marshall Wace
United Kingdom
-$86.9M
5
ESCM
Echo Street Capital Management
New York
-$65.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
PMFA
626
Plante Moran Financial Advisors
Michigan
$2K -$2.47K -8 -50%
CTC
627
Central Trust Company
Missouri
$2K – – –
LFG
628
Larson Financial Group
Missouri
$2K – – –
SC
629
Sierra Capital
Florida
$2K – – –
VNA
630
Valley National Advisers
Pennsylvania
$2K – – –
MGIM
631
M&G Investment Management
United Kingdom
$1.59K +$311K +1,007 +22%
SC
632
Schubert & Co
Texas
$1K -$1.23K -4 -44%
FBT
633
First Bank & Trust
South Dakota
$1K – – –
Lazard Asset Management
634
Lazard Asset Management
New York
$1K +$617 +2 +100%
TWA
635
TCI Wealth Advisors
Arizona
$1K +$925 +3 New
DI
636
Disciplined Investments
Oklahoma
$1K +$1.23K +4 New
CI
637
Cordant Inc
Oregon
$1K +$1.54K +5 New
PCA
638
Providence Capital Advisors
North Carolina
$1K +$1.54K +5 New
SWA
639
Sutton Wealth Advisors
Florida
$568 -$925 -3 -60%
FGAM
640
Financial Gravity Asset Management
Texas
$380 -$2.64M -8,573 -91%
Macquarie Group
641
Macquarie Group
Australia
$345 -$29.6K -96 -7%
ITP
642
Iron Triangle Partners
Connecticut
– -$26.4M -70,000 Closed
JCM
643
Jag Capital Management
Missouri
– -$18.3M -48,452 Closed
SH
644
SeaTown Holdings
Singapore
– -$18.1M -48,128 Closed
Arrowstreet Capital
645
Arrowstreet Capital
Massachusetts
– -$17.7M -46,901 Closed
PM
646
Pembroke Management
Quebec, Canada
– -$13.4M -35,633 Closed
MFS
647
Mirabella Financial Services
United Kingdom
– -$11.5M -30,574 Closed
TC
648
TwinBeech Capital
New York
– -$9.23M -24,504 Closed
Allianz Asset Management
649
Allianz Asset Management
Germany
– -$8.62M -22,870 Closed
GGHC
650
Gilder Gagnon Howe & Co
New York
– -$8.22M -21,824 Closed
24 25
26
27 28

CRL Hedge Fund Activity: Q1 2022 in Review

644 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Charles River Laboratories (CRL) for Q1 2022, worth a combined $13.5B — down 24% from $17.7B a quarter earlier.

Sellers outnumbered buyers: 115 funds closed out of CRL and 60 opened new positions — a net loss of 55 holders — while 235 trimmed existing stakes and 262 added.

The largest buyer was Mackenzie Financial, adding an estimated $171M. The largest seller was Invesco, cutting an estimated $142M.

  • 644 institutional investors held Charles River Laboratories (CRL) as of Q1 2022, down from 707 in Q4 2021.
  • Funds reported $13.5B of Charles River Laboratories stock for Q1 2022, down 24% quarter-over-quarter.
  • 60 funds opened new Charles River Laboratories positions in Q1 2022 and 115 closed out, a net change of -55 holders.
  • The largest Charles River Laboratories buyer in Q1 2022 was Mackenzie Financial, an estimated $171M added.
  • The largest Charles River Laboratories seller in Q1 2022 was Invesco, an estimated $142M sold.

Based on aggregated 13F filings for Q1 2022.